IL7-IL12 Engineered Mesenchymal Stem Cells (MSCs) Improve A CAR T Cell Attack Against Colorectal Cancer Cells

URN to cite this document:: urn:nbn:de:bvb:355-epub-430479
DOI to cite this document:: 10.5283/epub.43047

Hombach, Andreas A. ; Geumann, Ulf ; Günther, Christine ; Hermann, Felix G. ; Abken, Hinrich

Preview

License: Creative Commons Attribution 4.0
PDF - Submitted Version
(2MB)

Date of publication of this fulltext: 08 Apr 2020 10:13

Alternative links to fulltext:DOI Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

Chimeric antigen receptor (CAR) redirected T cells are efficacious in the treatment of leukemia/lymphoma, however, showed less capacities in eliminating solid tumors which is thought to be partly due to the lack of cytokine support in the tumor lesion. In order to deliver supportive cytokines, we took advantage of the inherent ability of mesenchymal stem cells (MSCs) to actively migrate to tumor ...